Medicine, Hematology Oncology Division

Grants

Grants per year 1995 2007 2008 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2028

• 468 Active
• 1104 Finished

Grants per year

Search results

• A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study).

  Patel, J. D.

  SWOG - Clinical Trials Initiative LLC

  1/1/21 → 12/31/21

  Project: Research project

  • Non-Small Cell Lung Carcinoma 100%
  • Immunotherapy 98%
  • Lung Neoplasms 88%
  • Biomarkers 72%
  • Costs and Cost Analysis 46%

• Analysis of Acetylated Androgen Receptor for its Development as a Molecular Marker for Prostate Cancer and Target for Immunotherapy

  Lee, A. & Platanias, L. C.

  American Cancer Society

  1/1/19 → 12/31/21

  Project: Research project

  • cancer 100%
  • androgen 95%
  • marker 56%
  • pilot project 22%
  • research program 18%

• Optimizing Quality of Life in Women Living with Metastatic Breast Cancer: Feasibility and Preliminary Efficacy of a Tailored, eHealth Supportive Oncology Intervention

  Moreno, P. I. & Platanias, L. C.

  American Cancer Society

  1/1/19 → 12/31/21

  Project: Research project

  • quality of life 100%
  • breast neoplasms 97%
  • neoplasms 65%
  • funding 47%
  • government agencies 29%

• Biomarkers of Combined PD1 and VEGFR2 blockade in metastatic NSCLC

  Boumber, Y.

  Fox Chase Cancer Center, V Foundation for Cancer Research

  1/1/21 → 12/31/21

  Project: Research project

  • biomarkers 100%
  • human resources 53%
  • data analysis 51%

• C-097: Mininode: Injectable Reactor for Programmable Release of CAR T Cells to Solid Tumor

  Zhang, B.

  Searle Funds at The Chicago Community Trust

  1/1/17 → 12/31/21

  Project: Research project

• Prot #STU00206173: c-Met: A Potential Target for the Treatment of Advanced Ovarian Cancer

  Matei, D. E., Kocherginsky, M. & Shahabi, S.

  AbbVie Inc.

  12/1/17 → 12/31/21

  Project: Research project

  • Ovarian Neoplasms 100%
  • Drug Therapy 37%
  • Ovarian Epithelial Carcinoma 36%
  • Neoplasms 30%
  • Non-Small Cell Lung Carcinoma 28%

• Prot #201656: NU 14S03: A Phase II Study of Pazopanib with Oral Topotecan in Patients with Metastatic and Non-resectable Soft Tissue and Bone Sarcomas

  Agulnik, M.

  GlaxoSmithKline LLC

  2/10/15 → 12/31/21

  Project: Research project

• Coleman 4R Patient Care Sequences for Cancer and Supportive Care

  Garcia, S. F. & Gradishar, W. J.

  Coleman Foundation, Inc.

  10/1/18 → 12/31/21

  Project: Research project

  • Patient Care 100%
  • Neoplasms 53%
  • Patient Care Planning 34%
  • Patient-Centered Care 30%
  • Patient Rights 27%

• Evaluate the efficacy of VIC-1911 in prostate cancer cells

  Yu, J.

  VITRAC Therapeutics, LLC

  7/1/21 → 12/31/21

  Project: Research project

  • Aurora Kinase A 100%
  • DNA Damage 37%
  • MLN 8237 32%
  • Prostatic Neoplasms 29%
  • DNA Repair 28%

• Supportive Oncology Collaborative for Adolescents and Young Adults

  Garcia, S. F., Dinner, S. N., Kircher, S. M. & Sanford, S. D.

  Coleman Foundation, Inc.

  1/1/20 → 12/31/21

  Project: Research project

  • Young Adult 100%
  • Patient Care 43%
  • Palliative Care 26%
  • Caregivers 23%
  • Primary Health Care 21%

• A-016: Development of a Novel Treatment for Ovarian Cancer Based on Toxic RNA

  Peter, M. E.

  Searle Funds at The Chicago Community Trust

  1/1/17 → 12/31/21

  Project: Research project

• Prot #2003376607: NU JH17U01: Overcoming drug resistance in metastatic castration-resistant prostate cancer with novel combination of TGF-β receptor inhibitor LY2157299 and enzalutamide: a randomized multi-site phase II study

  Hussain, M. & Morgans, A. K.

  Johns Hopkins University

  9/1/17 → 12/31/21

  Project: Research project

• Institutional Research Grant

  Platanias, L. C.

  American Cancer Society

  1/1/19 → 12/31/21

  Project: Research project

  • neoplasms 100%
  • funding 73%
  • government agencies 45%
  • climate 25%

• Design and Implementation of a Patient-Centered, Post-Surgical, Post-Discharge Monitoring System after Gastrointestinal Cancer Surgery

  Merkow, R. P. & Platanias, L. C.

  American Cancer Society

  1/1/19 → 12/31/21

  Project: Research project

  • gastrointestinal neoplasms 100%
  • surgery 57%
  • neoplasms 43%
  • monitoring 36%
  • funding 32%

• Prot #NS-018-101: A Phase 1/2, Open-label, Dose-escalation, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered NS-018 in Patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofib

  Stein, B. L.

  Parexel, NS Pharma, Inc.

  12/13/12 → 12/31/21

  Project: Research project

• Therapy Consortium Award

  Hussain, M.

  Prostate Cancer Foundation

  5/1/17 → 12/31/21

  Project: Research project

  • cancer 100%

• Arginine methylation in mediating epigenetic balance in breast cancer

  Platanias, L. C. & Wang, L.

  American Cancer Society

  1/1/19 → 12/31/21

  Project: Research project

  • breast neoplasms 100%
  • epigenetics 86%
  • methylation 82%
  • arginine 75%
  • neoplasms 66%

• Prot #EMR 100070-001: A Phase I, Open-Label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects with Metastatic or Locally Advanced Solid Tumors a

  Kircher, S. M. & Nimeiri, H. S.

  Quintiles, Inc., EMD Serono, Inc.

  12/10/15 → 12/10/21

  Project: Research project

• Prot #EZH-202: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma

  Agulnik, M.

  Medpace, Inc., Epizyme, Inc.

  12/7/15 → 12/7/21

  Project: Research project

• Prot #MO39196: A Phase III, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination with Paclitaxel Compared with Placebo with Paclitaxel for Patients with Previously Untreated Inoperable Locall

  Gradishar, W. J.

  PRA Health Sciences, Genentech, Inc.

  11/15/17 → 11/30/21

  Project: Research project

• Prot #Pevonedistat-1015: A Phase 1 Study to Evaluate the Effects of Rifampin on Pharmacokinetics of Pevonedistat in Patients with Advanced Solid Tumors

  Mahalingam, D.

  PRA Health Sciences, Millennium Pharmaceuticals, Inc

  11/28/18 → 11/28/21

  Project: Research project

• Fellowship in support of Paola D'Amico

  Cristofanilli, M.

  American-Italian Cancer Foundation

  8/1/19 → 11/20/21

  Project: Research project

  • Neoplasms 100%

• Prot #MK-3475-062-00: A Randomized, Active-Controlled, Partially Blinded, Biomarker Select, Phase III Clinical Trial of Pembrolizumab as Monotherapy and in Combination with Cisplatin+5-Fluorouracil versus Placebo+Cisplatin+5-Fluorouracil as First-Line Tre

  Benson III, A. B.

  Merck Sharp & Dohme Corporation

  11/18/15 → 11/18/21

  Project: Research project

• Prot #2215-CL-1101: Phase 1/2 Study of ASP2215 (Gilteritinib) Combined with Atezolizumab in Patients with Relapsed or Treatment Refractory FLT3 Mutated Acute Myeloid Leukemia (AML)

  Altman, J. K.

  Syneos Health, Inc., Astellas Pharma Global Development, Inc.

  4/23/19 → 11/15/21

  Project: Research project

• Prot #NU MS16H07: Phase II Multicenter Study of Natalizumab Plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease

  Adekola, K.

  Icahn School of Medicine at Mount Sinai, Biogen Inc.

  9/1/16 → 11/2/21

  Project: Research project